STREAMEX CORP. Financing Cash Flow
STREAMEX CORP. (STEX) reported Financing Cash Flow of -$1.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- STREAMEX CORP. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$245.00K.
- STREAMEX CORP. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$1.64M, a 134.83% decline year-over-year.
- STREAMEX CORP. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $36.78M, a 3677900.00% increase year-over-year.
- STREAMEX CORP. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $13.40M.
- STREAMEX CORP. net cash provided by (used in) financing activities for fiscal 2025 was $54.88M, a 1065.10% increase from fiscal 2024.
- STREAMEX CORP. net cash provided by (used in) financing activities for fiscal 2024 was $4.71M, a 72.82% decline from fiscal 2023.
- STREAMEX CORP. net cash provided by (used in) financing activities for fiscal 2023 was $17.33M, a 63.96% increase from fiscal 2022.
- STREAMEX CORP. net cash provided by (used in) financing activities for fiscal 2022 was $10.57M, a 2.31% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.88M 10-Q · filed 2026-08-14 | $34.90M derived: sum of 3 quarters · filed 2026-08-14 | $48.29M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$1.64M 10-Q · filed 2026-05-14 | $35.14M derived: sum of 2 quarters · filed 2026-05-14 | $48.54M derived: sum of 3 quarters · filed 2026-05-14 | $48.54M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $36.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $50.18M derived: sum of 2 quarters · filed 2026-03-31 | $50.18M derived: sum of 3 quarters · filed 2026-08-14 | $54.88M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $13.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $13.40M derived: sum of 2 quarters · filed 2026-08-14 | $18.10M 10-Q · filed 2025-11-14 | $18.10M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.70M 10-Q · filed 2026-08-14 | $4.70M derived: sum of 3 quarters · filed 2026-08-14 | $4.70M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $4.70M 10-Q · filed 2026-05-14 | $4.70M derived: sum of 2 quarters · filed 2026-05-14 | $4.70M derived: sum of 3 quarters · filed 2026-05-14 | $7.87M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.00K derived: sum of 2 quarters · filed 2026-03-31 | $3.17M derived: sum of 3 quarters · filed 2026-03-31 | $4.71M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $3.17M derived: sum of 2 quarters · filed 2025-11-14 | $4.71M 10-Q · filed 2025-11-14 | $7.46M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $4.71M 10-Q · filed 2025-08-15 | $7.46M derived: sum of 3 quarters · filed 2025-08-15 | $10.48M derived: sum of 4 quarters · filed 2025-08-15 | ||||
| 2024-03-31 | $1.54M 10-Q · filed 2025-05-19 | $4.29M derived: sum of 2 quarters · filed 2025-05-19 | $7.31M derived: sum of 3 quarters · filed 2025-05-19 | $12.12M derived: sum of 4 quarters · filed 2025-05-19 | ||||
| 2023-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $5.77M derived: sum of 2 quarters · filed 2025-04-15 | $10.58M derived: sum of 3 quarters · filed 2025-04-15 | $17.33M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $7.84M derived: sum of 2 quarters · filed 2024-11-14 | $14.59M 10-Q · filed 2024-11-14 | $18.23M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $11.56M 10-Q · filed 2024-08-14 | $15.20M derived: sum of 3 quarters · filed 2024-08-14 | $16.01M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $6.75M 10-Q · filed 2024-05-20 | $10.39M derived: sum of 2 quarters · filed 2024-05-20 | $11.20M derived: sum of 3 quarters · filed 2024-05-20 | $14.32M derived: sum of 4 quarters · filed 2024-05-20 | ||||
| 2022-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $4.45M derived: sum of 2 quarters · filed 2024-04-16 | $7.57M derived: sum of 3 quarters · filed 2024-04-16 | $10.57M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.93M derived: sum of 2 quarters · filed 2023-11-14 | $6.93M 10-Q · filed 2023-11-14 | $6.93M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $6.12M 10-Q · filed 2023-08-14 | $6.12M derived: sum of 3 quarters · filed 2023-08-14 | $15.13M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-15 | $3.00M derived: sum of 2 quarters · filed 2023-05-15 | $12.01M derived: sum of 3 quarters · filed 2023-05-15 | $12.01M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $9.00M derived: sum of 2 quarters · filed 2023-03-31 | $9.00M derived: sum of 3 quarters · filed 2023-03-31 | $10.33M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $9.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $9.01M derived: sum of 2 quarters · filed 2022-11-14 | $10.33M 10-Q · filed 2022-11-14 | $11.98M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.33M 10-Q · filed 2022-08-15 | $2.98M derived: sum of 3 quarters · filed 2022-08-15 | $5.11M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $1.33M 10-Q · filed 2022-05-16 | $2.98M derived: sum of 2 quarters · filed 2022-05-16 | $5.11M derived: sum of 3 quarters · filed 2022-05-16 | $34.82M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.78M derived: sum of 2 quarters · filed 2022-03-31 | $33.49M derived: sum of 3 quarters · filed 2022-03-31 | $42.85M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $31.84M derived: sum of 2 quarters · filed 2021-11-15 | $41.20M 10-Q · filed 2021-11-15 | $41.20M 10-Q · filed 2020-11-05 | $44.99M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $29.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $39.07M 10-Q · filed 2021-08-11 | $39.07M 10-Q · filed 2020-08-06 | $42.86M derived: sum of 3 quarters · filed 2021-08-11 | $48.81M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $9.35M 10-Q · filed 2021-05-17 | $9.35M 10-Q · filed 2020-05-11 | $13.15M derived: sum of 2 quarters · filed 2021-05-17 | $19.10M derived: sum of 3 quarters · filed 2021-05-17 | $22.70M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $9.74M derived: sum of 2 quarters · filed 2021-03-15 | $13.35M derived: sum of 3 quarters · filed 2021-03-15 | $23.43M 10-K · filed 2021-03-15 | $23.43M 10-K · filed 2020-03-13 | |||
| 2019-09-30 | $5.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.56M derived: sum of 2 quarters · filed 2020-11-05 | $19.63M 10-Q · filed 2020-11-05 | $19.83M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.68M 10-Q · filed 2020-08-06 | $13.88M derived: sum of 3 quarters · filed 2020-08-06 | $19.96M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $10.08M 10-Q · filed 2020-05-11 | $10.28M derived: sum of 2 quarters · filed 2020-05-11 | $16.36M derived: sum of 3 quarters · filed 2020-05-11 | $21.67M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $197.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $6.28M derived: sum of 2 quarters · filed 2020-03-13 | $11.59M derived: sum of 3 quarters · filed 2020-03-13 | $13.47M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $11.39M derived: sum of 2 quarters · filed 2019-10-23 | $13.27M 10-Q · filed 2019-10-23 | $16.84M derived: sum of 4 quarters · filed 2019-10-23 | ||||
| 2018-06-30 | $5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $7.19M 10-Q · filed 2019-07-31 | $10.76M derived: sum of 3 quarters · filed 2019-07-31 | $11.88M derived: sum of 4 quarters · filed 2019-07-31 | ||||
| 2018-03-31 | $1.88M 10-Q · filed 2019-04-15 | $5.45M derived: sum of 2 quarters · filed 2019-04-15 | $6.57M derived: sum of 3 quarters · filed 2019-04-15 | $8.05M derived: sum of 4 quarters · filed 2019-04-15 | ||||
| 2017-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $4.69M derived: sum of 2 quarters · filed 2019-03-15 | $6.17M derived: sum of 3 quarters · filed 2019-03-15 | $7.97M 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $2.60M derived: sum of 2 quarters · filed 2018-11-02 | $4.40M 10-Q · filed 2018-11-02 | $6.57M derived: sum of 4 quarters · filed 2018-11-02 | ||||
| 2017-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $3.28M 10-Q · filed 2018-07-27 | $5.45M derived: sum of 3 quarters · filed 2018-07-27 | $5.98M derived: sum of 4 quarters · filed 2018-07-27 | ||||
| 2017-03-31 | $1.80M 10-Q · filed 2018-05-04 | $3.97M derived: sum of 2 quarters · filed 2018-05-04 | $4.50M derived: sum of 3 quarters · filed 2018-05-04 | $6.67M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2016-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.70M derived: sum of 2 quarters · filed 2018-02-27 | $4.87M derived: sum of 3 quarters · filed 2018-02-27 | $5.23M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $530.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.70M derived: sum of 2 quarters · filed 2017-11-09 | $3.05M 10-Q · filed 2017-11-09 | $4.77M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.52M 10-Q · filed 2017-08-10 | $4.24M derived: sum of 3 quarters · filed 2017-08-10 | $4.24M derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | $352.00K 10-Q · filed 2017-05-09 | $2.07M derived: sum of 2 quarters · filed 2017-05-09 | $2.07M derived: sum of 3 quarters · filed 2017-05-09 | $2.57M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $1.72M derived: sum of 2 quarters · filed 2017-04-11 | $2.21M derived: sum of 3 quarters · filed 2017-04-11 | $5.26M 10-K · filed 2017-04-11 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $495.88K derived: sum of 2 quarters · filed 2016-11-14 | $3.54M 10-Q · filed 2016-11-14 | $3.97M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $495.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $3.54M 10-Q · filed 2016-08-12 | $3.97M derived: sum of 3 quarters · filed 2016-08-12 | $4.77M derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | $3.04M 10-Q · filed 2016-05-04 | $3.47M derived: sum of 2 quarters · filed 2016-05-04 | $4.28M derived: sum of 3 quarters · filed 2016-05-04 | $4.77M derived: sum of 4 quarters · filed 2016-05-04 | ||||
| 2014-12-31 | $432.12K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.24M derived: sum of 2 quarters · filed 2016-03-14 | $1.73M derived: sum of 3 quarters · filed 2016-03-14 | $1.94M 10-K · filed 2016-03-14 | ||||
| 2014-09-30 | $804.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $1.30M derived: sum of 2 quarters · filed 2015-11-13 | $1.51M 10-Q · filed 2015-11-13 | $1.84M derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | $493.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $702.38K 10-Q · filed 2015-07-28 | $1.03M derived: sum of 3 quarters · filed 2015-07-28 | $1.32M derived: sum of 4 quarters · filed 2015-07-28 | ||||
| 2014-03-31 | $208.94K 10-Q · filed 2015-05-01 | $539.20K derived: sum of 2 quarters · filed 2015-05-01 | $823.54K derived: sum of 3 quarters · filed 2015-05-01 | |||||
| 2013-12-31 | $330.25K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $614.60K derived: sum of 2 quarters · filed 2015-02-20 | $2.05M 10-K · filed 2015-02-20 | |||||
| 2013-09-30 | $284.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-17 | $1.72M 10-Q · filed 2014-10-17 | ||||||
| 2013-06-30 | $1.44M 10-Q · filed 2014-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |